Cargando…

Prostate cancer between prognosis and adequate/proper therapy

Knowing the indolent, non-invasive nature of most types of prostate cancer, as well as the simple fact that the disease seems more likely to be associated with age rather than with other factors (50% of men at the age of 50 and 80% at the age of 80 have it [1], with or without presenting any symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Grozescu, T, Popa, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304372/
https://www.ncbi.nlm.nih.gov/pubmed/28255369
_version_ 1782506872768561152
author Grozescu, T
Popa, F
author_facet Grozescu, T
Popa, F
author_sort Grozescu, T
collection PubMed
description Knowing the indolent, non-invasive nature of most types of prostate cancer, as well as the simple fact that the disease seems more likely to be associated with age rather than with other factors (50% of men at the age of 50 and 80% at the age of 80 have it [1], with or without presenting any symptom), the big challenge of this clinical entity was to determine severity indicators (so far insufficient) to guide the physician towards an adequate attitude in the clinical setting. The risk of over-diagnosing and over-treating many prostate cancer cases (indicated by all the major European and American studies) is real and poses many question marks. The present paper was meant to deliver new research data and to reset the clinical approach in prostate cancer cases.
format Online
Article
Text
id pubmed-5304372
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-53043722017-03-02 Prostate cancer between prognosis and adequate/proper therapy Grozescu, T Popa, F J Med Life Reviews Knowing the indolent, non-invasive nature of most types of prostate cancer, as well as the simple fact that the disease seems more likely to be associated with age rather than with other factors (50% of men at the age of 50 and 80% at the age of 80 have it [1], with or without presenting any symptom), the big challenge of this clinical entity was to determine severity indicators (so far insufficient) to guide the physician towards an adequate attitude in the clinical setting. The risk of over-diagnosing and over-treating many prostate cancer cases (indicated by all the major European and American studies) is real and poses many question marks. The present paper was meant to deliver new research data and to reset the clinical approach in prostate cancer cases. Carol Davila University Press 2017 /pmc/articles/PMC5304372/ /pubmed/28255369 Text en ©Carol Davila University Press This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Reviews
Grozescu, T
Popa, F
Prostate cancer between prognosis and adequate/proper therapy
title Prostate cancer between prognosis and adequate/proper therapy
title_full Prostate cancer between prognosis and adequate/proper therapy
title_fullStr Prostate cancer between prognosis and adequate/proper therapy
title_full_unstemmed Prostate cancer between prognosis and adequate/proper therapy
title_short Prostate cancer between prognosis and adequate/proper therapy
title_sort prostate cancer between prognosis and adequate/proper therapy
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304372/
https://www.ncbi.nlm.nih.gov/pubmed/28255369
work_keys_str_mv AT grozescut prostatecancerbetweenprognosisandadequatepropertherapy
AT popaf prostatecancerbetweenprognosisandadequatepropertherapy